These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 28926942)

  • 1. The Semi-Synthetic Peptide Lin-SB056-1 in Combination with EDTA Exerts Strong Antimicrobial and Antibiofilm Activity against Pseudomonas aeruginosa in Conditions Mimicking Cystic Fibrosis Sputum.
    Maisetta G; Grassi L; Esin S; Serra I; Scorciapino MA; Rinaldi AC; Batoni G
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28926942
    [No Abstract]   [Full Text] [Related]  

  • 2. Targeting
    Maisetta G; Grassi L; Esin S; Kaya E; Morelli A; Puppi D; Piras M; Chiellini F; Pifferi M; Batoni G
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31861859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Antimicrobial Peptide lin-SB056-1 and Its Dendrimeric Derivative Prevent
    Grassi L; Batoni G; Ostyn L; Rigole P; Van den Bossche S; Rinaldi AC; Maisetta G; Esin S; Coenye T; Crabbé A
    Front Microbiol; 2019; 10():198. PubMed ID: 30800115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineered cationic antimicrobial peptide (eCAP) prevents Pseudomonas aeruginosa biofilm growth on airway epithelial cells.
    Lashua LP; Melvin JA; Deslouches B; Pilewski JM; Montelaro RC; Bomberger JM
    J Antimicrob Chemother; 2016 Aug; 71(8):2200-7. PubMed ID: 27231279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of artificial sputum medium to test antibiotic efficacy against Pseudomonas aeruginosa in conditions more relevant to the cystic fibrosis lung.
    Kirchner S; Fothergill JL; Wright EA; James CE; Mowat E; Winstanley C
    J Vis Exp; 2012 Jun; (64):e3857. PubMed ID: 22711026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial activity of synthetic cationic peptides and lipopeptides derived from human lactoferricin against Pseudomonas aeruginosa planktonic cultures and biofilms.
    Sánchez-Gómez S; Ferrer-Espada R; Stewart PS; Pitts B; Lohner K; Martínez de Tejada G
    BMC Microbiol; 2015 Jul; 15():137. PubMed ID: 26149536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymyxin B and ethylenediaminetetraacetic acid act synergistically against
    Hale SJM; Cameron AJ; Lux CA; Biswas K; Kim R; O'Carroll M; Harris PWR; Douglas RG; Wagner Mackenzie B
    Microbiol Spectr; 2024 Feb; 12(2):e0170923. PubMed ID: 38168683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Antimicrobial Peptide Gad-1 Clears Pseudomonas aeruginosa Biofilms under Cystic Fibrosis Conditions.
    Portelinha J; Angeles-Boza AM
    Chembiochem; 2021 May; 22(9):1646-1655. PubMed ID: 33428273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of a novel antimicrobial peptide against Pseudomonas aeruginosa biofilms.
    Beaudoin T; Stone TA; Glibowicka M; Adams C; Yau Y; Ahmadi S; Bear CE; Grasemann H; Waters V; Deber CM
    Sci Rep; 2018 Oct; 8(1):14728. PubMed ID: 30283025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cysteamine (Lynovex®), a novel mucoactive antimicrobial & antibiofilm agent for the treatment of cystic fibrosis.
    Charrier C; Rodger C; Robertson J; Kowalczuk A; Shand N; Fraser-Pitt D; Mercer D; O'Neil D
    Orphanet J Rare Dis; 2014 Nov; 9():189. PubMed ID: 25433388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential novel therapeutic strategies in cystic fibrosis: antimicrobial and anti-biofilm activity of natural and designed α-helical peptides against Staphylococcus aureus, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia.
    Pompilio A; Crocetta V; Scocchi M; Pomponio S; Di Vincenzo V; Mardirossian M; Gherardi G; Fiscarelli E; Dicuonzo G; Gennaro R; Di Bonaventura G
    BMC Microbiol; 2012 Jul; 12():145. PubMed ID: 22823964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chelator-induced dispersal and killing of Pseudomonas aeruginosa cells in a biofilm.
    Banin E; Brady KM; Greenberg EP
    Appl Environ Microbiol; 2006 Mar; 72(3):2064-9. PubMed ID: 16517655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo activity of EDTA and antibacterial agents against the biofilm of mucoid Pseudomonas aeruginosa.
    Liu Z; Lin Y; Lu Q; Li F; Yu J; Wang Z; He Y; Song C
    Infection; 2017 Feb; 45(1):23-31. PubMed ID: 27189338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic susceptabilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions.
    Hill D; Rose B; Pajkos A; Robinson M; Bye P; Bell S; Elkins M; Thompson B; Macleod C; Aaron SD; Harbour C
    J Clin Microbiol; 2005 Oct; 43(10):5085-90. PubMed ID: 16207967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bactericidal activities of cathelicidin LL-37 and select cationic lipids against the hypervirulent Pseudomonas aeruginosa strain LESB58.
    Wnorowska U; Niemirowicz K; Myint M; Diamond SL; Wróblewska M; Savage PB; Janmey PA; Bucki R
    Antimicrob Agents Chemother; 2015 Jul; 59(7):3808-15. PubMed ID: 25870055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic antibiofilm efficacy of various commercial antiseptics, enzymes and EDTA: a study of Pseudomonas aeruginosa and Staphylococcus aureus biofilms.
    Lefebvre E; Vighetto C; Di Martino P; Larreta Garde V; Seyer D
    Int J Antimicrob Agents; 2016 Aug; 48(2):181-8. PubMed ID: 27424598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Competition in Biofilms between Cystic Fibrosis Isolates of
    Oluyombo O; Penfold CN; Diggle SP
    mBio; 2019 Jan; 10(1):. PubMed ID: 30696740
    [No Abstract]   [Full Text] [Related]  

  • 18. Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients.
    Bjarnsholt T; Jensen PØ; Fiandaca MJ; Pedersen J; Hansen CR; Andersen CB; Pressler T; Givskov M; Høiby N
    Pediatr Pulmonol; 2009 Jun; 44(6):547-58. PubMed ID: 19418571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The assessment of the antibacterial and antifungal activities of aspirin, EDTA and aspirin-EDTA combination and their effectiveness as antibiofilm agents.
    Al-Bakri AG; Othman G; Bustanji Y
    J Appl Microbiol; 2009 Jul; 107(1):280-6. PubMed ID: 19302313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibacterial and Antibiofilm Effects of Lactobacilli Strains against Clinical Isolates of
    Batoni G; Catelli E; Kaya E; Pompilio A; Bianchi M; Ghelardi E; Di Bonaventura G; Esin S; Maisetta G
    Antibiotics (Basel); 2023 Jul; 12(7):. PubMed ID: 37508254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.